AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(0.69) per share. This is a 1280 percent decrease over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $22.000 thousand which missed the analyst consensus estimate of $100.000 thousand by 78.00 percent. This is a 37.50 percent increase over sales of $16.000 thousand the same period last year.